After operating in secrecy for years, a startup company called R3 Bio, in Richmond, California, suddenly shared details about its work last week—saying it had raised money to create nonsentient monkey “organ sacks” as an alternative to animal testing. In an interview with Wired, R3 listed three investors: billionaire Tim Draper, the Singapore-based fund Immortal…
The move to diversify its AI partnerships by tapping the shoulder of OpenAI’s top rival comes as the AI company also pursues independence from Microsoft with its own AI infrastructure and a potential LinkedIn competitor.